Streetbeat News

Assets

CARM

CARISMA Therapeutics has reported Q3 cash, cash equivalents, and marketable securities of $94.1M. This is expected to fund the company into the first quarter of 2025.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:58 pm

CABA

Cabaletta Bio reported Q3 losses of $(0.37) per share, beating the analyst consensus estimate of $(0.40) by 7.5%. This is a 5.13% increase over losses from the same period last year. The company's cash, cash equivalents and short-term investments of $164.4M are expected to support operations into Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:44 pm

GLUE

Monte Rosa Therapeutics (NASDAQ:GLUE) reported Q3 losses of $(0.70) per share, beating the analyst consensus estimate of $(0.72) by 2.78%. This is a 20.69% decrease over losses of $(0.58) per share from the same period last year. The company's cash, cash equivalents, restricted cash, and marketable securities of $183M are sufficient to fund planned operations and capital expenditures into 1H of 2026.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:38 pm

KELYA

Kelly Services (KELYA) anticipates the sale of its European staffing operations and the results of its growth initiatives to drive further expansion of its adjusted EBITDA margin.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:34 pm

IKNA

Ikena Oncology's Q3 report shows cash, cash equivalents, and marketable securities of $196.9M. This is expected to provide a cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:33 pm

TCRX

TScan Therapeutics reported ending Q3 with cash, cash equivalents, and marketable securities of $215.4M. This amount is expected to fund the company's operations into 2026.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:28 pm

MNPR

Monopar Therapeutics reported Q3 losses of $(0.14) per share, beating the analyst consensus estimate of $(0.17) by 17.65%. This is a 26.32% increase over losses from the same period last year. The company's cash, cash equivalents and short-term investments of $8.5M are estimated to fund its operations at least through November 2024.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:27 pm

GLP

Global Partners LP has agreed to acquire 25 liquid energy terminals from Motiva Enterprises LLC for $305.8 million in cash. This acquisition is expected to expand Global Partners' footprint in the liquid energy market.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:20 pm

APYX

Apyx Medical Corporation has announced a new debt facility with Perceptive Advisors. The facility includes senior, secured term loans of up to $45M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:09 pm

AAPL

Apple Inc. co-founder Steve Wozniak has been hospitalized in Mexico City after fainting at a business event. The exact cause is not known yet, but local media reports suggest that Wozniak may have suffered a stroke or experienced vertigo. Wozniak, who left Apple in 1985, was in Mexico City to attend the World Business Forum.

Portfolio Pulse from Rounak Jain

November 09, 2023 | 12:07 pm